help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MAUAD, T.
Right arrow Articles by DOLHNIKOFF, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MAUAD, T.
Right arrow Articles by DOLHNIKOFF, M.
Am. J. Respir. Crit. Care Med., Volume 160, Number 3, September 1999, 968-975

Elastosis and Fragmentation of Fibers of the Elastic System in Fatal Asthma

THAIS MAUAD, ANA CAROLINA GALTAROSSA XAVIER, PAULO HILÁRIO NASCIMENTO SALDIVA, and MARISA DOLHNIKOFF

Department of Pathology, Faculty of Medicine, São Paulo University, São Paulo, Brazil

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Fibers of the elastic system (FES) are important in regulating airway patency and lung elastic recoil. Their possible role in modulating bronchoconstriction is not fully understood. Chronic inflammation and mechanical stretching present in asthma could lead to conformational alterations in the FES, participating in the mechanism of airway remodeling observed in this disease. In airway mucosa, two layers of FES are discernible: one superficial network, attached to the basement membrane, and a deeper network, lying close to the airway smooth muscle. Using image analysis and conventional morphometry, we analyzed airway content of FES in central and peripheral airways in 31 cases of fatal asthma and in 10 control lungs. Slides were stained using the oxidized resorcin-fuchsin method. Optical analysis revealed fragmentation of the FES in the superficial network of central asthmatic airways. Morphometry showed the presence of elastosis in central asthmatic airways when the entire thickness of the mucosa was considered. In the superficial network elastic fiber content was significantly decreased. These results indicate that FES participate in airway remodeling in asthma. We also suggest that disrupture of fiber attachments at the basement membrane in the superficial layer could impair the mechanism of airway recoil in asthmatic patients.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Structural alterations present in airway walls of severe and fatal asthma have been classically described (1, 2). The presence of a chronic inflammation resulting in healing and repair leads ultimately to airway remodeling. The failure to adequately repair the inflammatory damage possibly contributes to the airway hyperresponsiveness and changes in airway mechanics observed in this disease (3). The decline of the ventilatory function over time in some asthmatic patients may be a consequence of airway remodeling (4).

The relationship between structure and function in asthma has been extensively studied. All the compartments of the airway have been shown to have some structural alteration contributing to functional defects (5). Morphometric analysis of asthmatic airways suggests that thickening of the airway wall internal to the muscle layer could increase the effect of a given amount of smooth muscle shortening on airway narrowing (6).

The major extracellular matrix components of the lungs include collagen, elastin, proteoglycans (7), and fibronectin (8). Changes in the extracellular matrix components have already been described in asthma (5, 9, 10). Altered amount or composition of extracellular matrix components, individually or as a network, may contribute to changes in airway mechanics through geometric effects, direct changes in tissue biomechanics, and by altered modulation of the process of inflammation itself (5).

Subepithelial deposition of collagen types I, III, and V and fibronectin in the lamina reticularis beneath the bronchial epithelium has been observed, even in cases of mild asthma (9). Thickening underneath the true basement membrane caused by collagen deposition has also been described in asthmatic children (11). Although there are a number of studies describing collagen changes in asthmatic airways, few reports concern the distribution and configuration of the fibers of the elastic system in this disease.

The elastic system has three components, oxytalan, elaunin, and elastic fibers, defined according to crescent amounts of elastin and fibril orientation (12, 13). Oxytalan fibers are devoid of elastin and, in the organs where they have been described, oxytalan fibers are always anchoring basement membranes and have a mechanical rather than an elastic role (12). In the bronchial lamina propria FES are found as a superficial network underlying the basement membrane, connected to a loose meshwork of coarse fibers close to the smooth muscle (deeper network or lamina elastica) (14). These fibers are connected to the airway adventitia through thin fibers that traverse the airway smooth muscle (15).

Fibers of the elastic system (FES) provide support for airway patency and lung elastic recoil (8). However, their potential role in modulating bronchoconstriction has not yet been described. Because of their mechanical properties and configuration in the airway, FES may act as structures limiting airway constriction and may also provide tension to restore airways to their preconstricted configuration after the contractile stimulus has ceased (15).

There is no consensus in the literature about elastic changes in asthmatic airways. In a descriptive study, Bousquet and colleagues (10) reported fragmentation and paucity of fibers in the subepithelial layer in bronchial biopsies of asthmatics of different severity, with a picture similar to the solar elastolysis of the skin. On the other hand, Godfrey and coworkers (16) could not find differences in the total content of FES in airways in cases of mild, severe, and fatal asthma when compared with control subjects.

This controversy and the potential role of these fibers in contributing to the physiopathology of asthma led us to quantify the FES in asthmatic airways, focusing both total mucosa and superficial layer fiber content.

    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects

Thirty-one patients dying of status asthmaticus were selected from our autopsy service. This service is characterized by draining patients from all over the city, including emergency services in the outskirts of the city of São Paulo and patients dying at home. The pathologists work with very little clinical information. Clinical charts or detailed medical history are, in many instances, absent. Information concerning main diseases such as asthma, diabetes, heart disease is obtained from a brief questionnaire that is applied to relatives prior to autopsy. All patients in this study were known to be asthmatics and died during a severe crisis of breathlessness. The diagnosis of fatal asthma was confirmed by macroscopic examination (lungs overinflated) and histologic criteria (mucous plugs, mucosal foldings, epithelium desquamation, mucosal inflammation rich in eosinophils, and hyaline thickening of the basement membrane) (Figure 1A). None of the specimens showed chronic bronchitis, emphysema, or pneumonia. Ten control subjects were selected, dying from causes other than pulmonary disease. None of the control subjects were smokers. All control cases had a normal gross and microscopic examination of the lungs (Figure 1B). Patients younger than 14 and older than 60 yr of age were not included in either group.


View larger version (160K):
[in this window]
[in a new window]
 
Figure 1.   Central asthmatic airway (A). Note mucus plugging (m), hyaline thickening of basement membrane (bm), and inflammatory infiltrate containing eosinophils (arrow); c = cartilage (H&E). Central airway of a control lung, c = cartilage (B). There is no airway constriction or inflammation (H&E). Elastic fiber distribution in asthmatic (C ) and control (D) central airways. Control central airway shows two distinct layers of FES. One (thin arrow) lies perpendicular to basement membrane (bm) and the other (thick arrow) lies parallel to airway smooth muscle (asterisk). In central asthmatic airway, there is elastosis and fibers are approximated with a condensed aspect (arrow). Weigert's resorcin-fuchsin with oxidation staining. FES are decreased in the subepithelial layer (SL) of the central asthmatic airway (E ), when compared with control (F ). Weigert's resorcin-fuchsin with oxidation staining. Scale bar = 100 µm.

Histochemistry

Lung tissue was fixed with 4% paraformaldehyde, embedded in paraffin, and processed routinely. Slices 5 µm thick were cut and stained with hematoxylin-eosin and Weigert's resorcin-fuchsin with oxidation (17). Oxidation was performed using oxone as previously described (18). This histochemical method allows for identification of all the three components of the elastic fiber system, i.e., elastic, elaunin, and oxytalan fibers.

Morphometrical Procedure

Airways were divided into central (CA) or peripheral (PA) areas according to the presence or absence of cartilage, respectively. To estimate airway dimensions we assessed bronchial diameters by image analysis in a sample of 20 central and 20 peripheral transversally cut airways by measuring basement membrane perimeter. Airways were defined as transversally cut when the relation between the maximal diameter and the diameter at the widest point perpendicular to this axis was > 0.6.

We measured total and subepithelial elastic fiber content in the airway mucosa These measures were assessed in 63 central asthmatic and 27 control airways. Sixty-four peripheral airways were measured in asthmatics and 28 in control subjects. The technique of measuring elastic fibers by image analysis has been validated mainly in skin studies (19). Mean values were calculated for each patient.

The total content of the fibers of the elastic system in the mucosa was assessed in a zone lying between the epithelial basement membrane and the internal limit of the airway smooth muscle (20). Using a magnification ×200, quantification was carried out with the aid of a digital analysis system, using specific Software (Bioscan-Optimas; Bioscan Incorporated, Edmond, WA). The images were generated by a microscope (Zeiss Axioplan; Zeiss, Oberkochen, Germany) connected to a camera (Sony Triniton CCD; Sony, Tokyo, Japan) and fed into a computer through a frame grabber (Oculus TCX; Coreco, St. Laurent, PQ, Canada) for off-line processing. We analyzed 15 fields in each CA and the total circumference in PA (five to six fields per airway), with a mean of three CA and three PA per case. Mean values were calculated for each airway, and subsequently a mean value was obtained for each patient. The elastic content was assessed for each field and the corresponding length of the basement membrane was measured. In order to avoid the effects of acute bronchoconstriction in the measures, the total elastic content was expressed as a ratio between area of elastic tissue and basement membrane length, results being expressed in micrometers. According to James and colleagues (6) airway internal perimeter remains constant with different degrees of airway smooth muscle shortening, despite substantial changes in luminal area.

In central airways we also quantified the fibers lying in the subepithelial zone, i.e., the zone immediately underneath the basement membrane (10 µm deep). For this procedure, conventional morphometric analysis was adopted. A semicircular coherent grid (Merz grid), used for anisotropic systems, was attached to a video monitor, where fields had their images captured. Using magnification ×1,000, 40 fields per CA were assessed, one to three bronchi per patient. The amount of elastic fibers was expressed as the number of fibers intercepting the grid per field.

In peripheral airways, we could not identify two distinct layers, and therefore only total elastic content was measured.

Data Analysis

An unpaired two-tailed t test was used to compare the content of FES in the mucosa of asthmatics and control subjects. Results were considered statistically significant at a probability level of 5%.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects

Asthmatic patients ranged from 14 to 58 yr of age (mean ± SD: 38.87 ± 12.51), including 17 female and 14 male patients. The mean ± SD age of control subjects was 37.4 ± 11.9 yr, ranging from 20 to 54 yr, including eight female and two male patients. The causes of the death of the control subjects are shown in Table 1.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 1

CAUSE OF DEATH IN CONTROL SUBJECTS

Light Microscopy

In central airways two layers of FES were discernible: one deeper layer composed of thick fibers lying parallel to the airway smooth muscle and another one, perpendicular, found closer to the basement membrane. This superficial perpendicular layer was neatly organized in short bundles (Figure 1D). Weigert's resorcin-fuchsin with oxidation staining allowed for further identification of thin fibers anchoring the basement membrane, connected to the superficial layer (Figure 1F). These slender fibers have already been described by Böck and Stockinger (14) and correspond to oxytalan fibers.

In asthmatic airways the most striking abnormalities were observed in the superficial network of CA. At this level the fibers were fragmented, disorganized, and sparse, immersed in an edematous stroma (Figure 1E). Fibers of the deep layer were tangled and seemed to be approximated in areas of bronchoconstriction, with a condensed aspect (Figure 1C). In peripheral airways only one layer of elastic fibers was discernible at optical level. The abnormalities in the FES were not so remarkable as observed in CA. The distribution of FES in normal airways and the alterations observed in asthmatics are schematically shown in Figure 2.


View larger version (43K):
[in this window]
[in a new window]
 
Figure 2.   Schematic drawing showing the distribution of FES in normal airways and the altered FES pattern observed in asthmatic airways. Adapted from Reference 14.

Morphometry

Airway diameters ranged from 0.65 to 0.21 cm in central airways and from 0.17 to 0.065 cm in peripheral airways, which correspond to Generation 3 to 9 for central airways and to Generation 10 to 13 for peripheral airways (21).

The mean values (µm) of total mucosal elastic content in CA in asthmatics and control subjects are shown in Tables 2 and 3. The mean values (µm) of total mucosal elastic content in PA in asthmatics and control subjects are shown in Tables 4 and 5. Total mucosal elastic content in asthmatics and control subjects for CA and PA is shown in Figure 3. There was a statistically significant increase in FES content in asthmatic CA. There was no difference in FES content in PA. Total elastic content in CA was 12.16 ± 1.65 µm in asthmatics and 7.95 ± 0.88 µm in control subjects (p = 0.03). In PA, total elastic content was 3.96 ± 0.33 µm in asthmatics and 3.01 ± 0.32 µm in control subjects (p = 0.09). The distribution of FES mucosal content according to patient's age in CA and PA, respectively, is shown in Figures 4 and 5. Note that CA elastosis tended to occur in patients older than 40 yr of age. For PA, FES content in asthmatics and control subjects did not vary with age.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 2

TOTAL MUCOSAL FES CONTENT IN CENTRAL AIRWAYS OF ASTHMATIC LUNGS

                              
View this table:
[in this window]
[in a new window]
 

TABLE 3

TOTAL MUCOSAL FES CONTENT IN CENTRAL AIRWAYS OF CONTROL LUNGS

                              
View this table:
[in this window]
[in a new window]
 

TABLE 4

TOTAL MUCOSAL FES CONTENT IN PERIPHERAL AIRWAYS OF ASTHMATIC LUNGS

                              
View this table:
[in this window]
[in a new window]
 

TABLE 5

TOTAL MUCOSAL FES CONTENT IN PERIPHERAL AIRWAYS OF CONTROL LUNGS


View larger version (35K):
[in this window]
[in a new window]
 
Figure 3.   Total mucosal content of FES, expressed in micrometers, in peripheral (PA) and central (CA) airways of asthmatic and control lungs. There was a statistically significant increase in FES content in asthmatics CA (p = 0.03). There was no statistical difference in FES content in PA (p = 0.09). Values are expressed as mean ± SEM.


View larger version (20K):
[in this window]
[in a new window]
 
Figure 4.   Distribution of FES total mucosal content in CA according to patients' ages (asthma and control). Data are expressed as mean ± SEM (µm).


View larger version (23K):
[in this window]
[in a new window]
 
Figure 5.   Distribution of FES total mucosal content in PA according to patients' ages (asthma and control), expressed as mean ± SEM (µm).

The mean values (number of intercepts) of superficial FES content in asthmatics and control subjects are shown in Tables 6 and 7, respectively. Morphometric assessment of FES content, expressed as the number of fibers intercepting the grid, in the subepithelial region in central airways of asthmatic and control patients is shown in Figure 6. There was a statistically significant decrease in FES content in asthmatic airways. Subepithelial elastic content was 5.30 ± 0.31 in asthmatics and 9.85 ± 0.46 in control subjects (p < 0.0001). The distribution of FES subepithelial superficial content in CA according to the patient's age is shown in Figure 7. Note that asthmatic patients of any age had a low fiber content when compared with control subjects.

                              
View this table:
[in this window]
[in a new window]
 

TABLE 6

FES CONTENT IN THE SUPERFICIAL NETWORK OF CENTRAL AIRWAYS OF LUNGS OF ASTHMATICS

                              
View this table:
[in this window]
[in a new window]
 

TABLE 7

FES CONTENT IN THE SUPERFICIAL NETWORK OF CENTRAL AIRWAYS OF LUNGS OF CONTROL SUBJECTS


View larger version (43K):
[in this window]
[in a new window]
 
Figure 6.   FES content in the superficial network of central airways in asthmatic and control lungs, expressed as numbers of fiber intercepts. There was a statistically significant decrease in the content of FES in asthmatics (p < 0.0001). Values are expressed as mean ± SEM.


View larger version (21K):
[in this window]
[in a new window]
 
Figure 7.   Distribution of FES subepithelial content in CA according to patients' ages (asthma and control). Data are expressed as number of intercepts.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Fibers of the elastic system, because of their natural properties (FES act returning an organ to its original conformation after release of a deforming force), are natural candidates to contribute to bronchoconstriction modulation. Impairment of FES in the airway wall is likely to contribute to airway hyperresponsiveness and also to prevent the airway from returning to its preconstricted status. Leick-Maldonado and coworkers (15) described, when studying the distribution of FES in bronchoconstricted intraparenchymatous guinea-pig airways, how there is a mechanism of delamination of the fibers within the subepithelial layer, part of them following the invaginations, attached to the basement membrane, the other remaining attached to the airway smooth muscle. This configuration is similar to what we observed in asthmatic bronchoconstricted airways and is compatible with the theory that FES participate in bronchoconstriction modulation.

It has already been demonstrated that interaction between parenchyma airway is important in the regulation of bronchoconstriction, as demonstrated in the experiments of Ding and colleagues (22). These investigators showed that the effects of bronchoconstrictive agents might be reversed by large inflation of the lungs. Less attention, however, has been devoted to the interactions occurring between airway smooth muscle and epithelial basement membrane in the constrictor event, and how the transmission of forces generated by airway smooth muscle are regulated by elements of the extracellular matrix.

Stephens and Jiang (23) have speculated that in central airways parenchymal tissue should not exert an important load to the airway smooth muscle constriction insofar as at this level the parenchyma does not attach to the wall directly but via a compliant connective tissue sheath. It is only at the tenth or eleventh generation that alveolar septa seem to insert directly on the wall of the airway. However, even at this level the intervening structures may possess considerable compliance. Using computer imaging, these investigators have shown that during bronchoconstriction there is no significant variation in the external perimeter of the airway, whereas there is a significant narrowing of the lumen, suggesting that some mechanism of recoil occurs within the airway wall itself. Furthermore, Bramley and coworkers (24), comparing airway strip mechanical properties, concluded that a reduced tissue elastance of nonmuscle elements within airway walls of asthmatic patients results in a greater muscle shortening by reducing the load limiting bronchoconstriction.

In the present study we quantified both superficial and deeper layer of FES in airways of patients dying of fatal asthma. Our results indicate for the first time the presence of elastosis in asthmatic central airways when the entire thickness of the mucosal layer is considered. The elastosis could be a result of repair and contribute to airway remodeling after inflammation and fiber fragmentation, as already suggested by Bousquet and colleagues (25).

In the subepithelial region (superficial network) of central airways we showed a paucity of elastic fibers. Fiber disrupture at this level could determine loss of attachments between submucosa and epithelium. We have speculated that since the elastic fiber system is a continuum network of fibers connecting the airway epithelium to the lung parenchyma, transmission of elastic forces within the airway wall would have a "weak point" at this region. Impairment of the elastic fiber network could contribute to airway hyperconstriction and to the impaired mechanism of airway recoil.

There is some evidence that airway wall remodeling may occur in both large and small airways, as demonstrated in some autopsy studies (26). We do not have a clear explanation for the lack of elastosis or significant morphologic alterations in the FES content and distribution in the peripheral airways. One possible explanation is that there is very little elastic tissue in smaller airways, and maybe our methods were not sensitive enough to bring up a statistically significant difference between asthmatics and control subjects (although there was a trend towards elastosis, as shown in Figure 3). On the other hand, there are few studies that suggest that airway inflammation in fatal asthma is less important in peripheral airways (27). If this is true, one could expect less elastic damage within peripheral airways because of chronic inflammation.

The chronic inflammatory infiltrate present in asthma produces proteases, including elastases and collagenases (28) released from various inflammatory cells such as macrophages (29), neutrophils (30), and even eosinophils (31). Recent work has shown increased levels of elastase and alpha 1-antitrypsin in the sputum of asthmatic patients (32). This chronic insult probably alters the FES and the other components of the extracellular matrix. Experimental work has shown that inhaled elastase can cause bronchoconstriction in guinea pigs (33). Furthermore, the edema and stretching of the airway observed in cases of fatal asthma could contribute to the fragmentation of the fibers (10). It is important to emphasize that our results are derived from fatal status asthmaticus, and some of the observed changes could be the result of the final attack. Although the presence of elastosis probably denotes a chronic repair of FES within the airway wall, the large amount of edema observed underneath the basement membrane may represent an acute additional damage to these fibers during the fatal attack.

Our observation that elastosis in central airways tended to occur in patients older than 40 yr of age (Figure 4) supports the idea that elastosis could follow repair after chronic, prolonged inflammation characteristic of the disease.

The lack of clinical data is the limiting factor of this autopsy study. In the present work all patients had a clinical history of asthma, but for some of the patients we do not have further information concerning cigarette smoking, cause and duration of asthma, and treatment. In all these cases death was ascribed as status asthmaticus. The lungs had a gross aspect compatible with fatal asthma: they were hyperinflated and contained tenacious mucous plugs in the bronchi. We also used histologic criteria to confirm the diagnosis: bronchoconstriction, (pseudo) hyaline thickening of the basement membrane, eosinophilic infiltrate, and mucous plugging. Each lung was included in our study only when most of these features were present. Indeed, we believe that we might have excluded some asthmatic patients from the study because of the rigid histologic criteria. Also, when signs of emphysema or "chronic bronchitis" were present we did not use the tissue. We have not used patients older than 60 and younger than 14 yr of age. Especially in the older population it may be very difficult to distinguish asthma from chronic obstructive pulmonary disease.

In summary, the present data show that both elastosis and elastic fiber fragmentation are present in asthmatic airway walls, indicating that FES may participate in airway remodeling. Our results also reinforce the idea that FES can contribute to the mechanism of bronchoconstriction.

    Footnotes

Correspondence and requests for reprints should be addressed to Dr. Thais Mauad, Departamento de Patologia, Faculdade de Medicina da Universidade de São Paulo, Av. Dr. Arnaldo, 455 1° andar, Cerqueira César - São Paulo - SP CEP: 01246-903, Brasil. E-mail: tmauad{at}usp.br

(Received in original form September 18, 1998 and in revised form February 16, 1999).

Acknowledgments: The writers are thankful to Prof. Gregorio Santiago Montes for his valuable suggestions and to the Laboratory of Cell Biology for performing the stainings. They are indebted to the pathologists and assistants of the autopsy service of the São Paulo University who helped gather this material. They also thank Dr. Mara S. Ludwig for critical comments and helpful suggestions.

Supported by CNPq, LIM 05 HC-FMUSP, and FAPESP.

    References
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1. Dunnill, M. S.. 1960. The pathology of asthma, with special reference to changes in the bronchial mucosa. J. Clin. Pathol. 13: 27-33 .

2. Jeffery, P. K.. 1992. Pathology of asthma. Br. Med. Bull. 48: 23-39 [Abstract/Free Full Text].

3. Irvin, C. G., and S. Wenzel. 1995. Asthma: structure and function. Chest 107: S85-S86 .

4. Lange, P., J. Parner, J. Vestbo, P. Schnohr, and G. Jensen. 1998. A 15-year follow-up study of ventilatory function in adults with asthma. N. Engl. J. Med. 339: 1194-1200 [Abstract/Free Full Text].

5. Roberts, C. R.. 1995. Is asthma a fibrotic disease? Chest 107: 111S-117S [Free Full Text].

6. James, A. L., P. D. Pare, and J. C. Hogg. 1989. The mechanics of airway narrowing in asthma. Am. Rev. Respir. Dis. 139: 242-246 [Medline].

7. Dolhnikoff, M., J. Morin, P. Roughley, and M. S. Ludwig. 1998. Expression of lumican in human lungs. Am. J. Respir. Cell Mol. Biol. 19: 582-587 [Abstract/Free Full Text].

8. Turino, G. M.. 1985. The lung parenchyma: a dynamic matrix. Am. Rev. Respir. Dis. 132: 1324-1334 [Medline].

9. Roche, W. R., J. H. Williams, R. Beasley, and S. T. Holgate. 1989. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1: 520-524 [Medline].

10. Bousquet, J., J. Y. Lacoste, P. Chanez, P. Vic, P. Godard, and F. B. Michel. 1996. Bronchial elastic fibers in normal subjects and asthmatic patients. Am. J. Respir. Crit. Care Med. 153: 1648-1654 [Abstract].

11. Cutz, E., H. Levinson, and D. M. Cooper. 1978. Ultrastructure of airways in children with asthma. Histopathology 2: 407-421 [Medline].

12. Cotta-Pereira, G., F. G. Rodrigo, and J. F. David-Ferreira. 1977. The elastic system fibers. In L. B. Sandberg, W. R. Gray, and C. Franzblau, editors. Advances in Experimental Medicine and Biology: Elastin and Elastic Tissue. Plenum Press, New York. 19-30.

13. Mecham, R. P. 1997. Elastic fibers. In R. G. Crystal, J. B. West, E. R. Weibel, and P. J. Barnes, editors. The Lung: Scientific Foundations. 2nd ed. Lippincott-Raven Publishers, New York. 729-736.

14. Böck, P., and L. Stockinger. 1984. Light and electron microscopic identification of elastic, elaunin and oxytalan fibers in human tracheal and bronchial mucosa. Anat. Embryol. 170: 145-153 [Medline].

15. Leick-Maldonado, E. A., M. Lemos, I. F. L. C. Tibério, E. G. Caldini, G. S. Montes, M. A. Martins, and P. H. N. Saldiva. 1997. Differential distribution of elastic system fibers in control and bronchoconstricted intraparenchymatous airways in the guinea-pig lung. J. Submicrosc. Cytol. Pathol. 29: 427-434 [Medline].

16. Godfrey, R. W. A., S. Lorimer, S. Majumdar, E. Adelroth, P. W. Johnston, A. V. Rogers, S. A. Johansson, and P. K. Jeffery. 1995. Airway and lung elastic fibre is not reduced in asthma nor in asthmatics following corticosteroid treatment. Eur. Respir. J. 8: 922-927 [Abstract].

17. Weigert, C.. 1898. Über eine Methode zur Farbung elastischer Fasern. Zentralbl. Allg. Pathol. Anat. 9: 289-292 .

18. Fullmer, H. M., J. H. Sheetz, and A. J. Narkates. 1974. Oxytalan connective tissue fibers: a review. J. Oral Pathol. 3: 291-316 [Medline].

19. Uitto, J., J. L. Paul, K. Brockley, R. H. Pearce, and J. G. Clark. 1983. Elastin fibers in human skin: quantitation of elastic fibers by computerized digital image analyses and determination of elastin by radioimmunoassay of desmosine. Lab. Invest. 49: 499-505 [Medline].

20. Bai, A., D. H. Eidelman, J. C. Hogg, A. L. James, R. K. Lambert, M. S. Ludwig, J. Martin, D. M. McDonald, W. A. Mitzner, M. Okazawa, R. J. Pack, P. D. Paré, R. R. Schellenberg, H. A. W. M. Tiddens, E. M. Wagner, and D. Yager. 1994. Proposed nomenclature for quantifying subdivisions of the bronchial wall. Special Communication. J. Appl. Physiol. 77: 1011-1014 [Abstract/Free Full Text].

21. Weibel, E. R., and C. R. Taylor. 1998. Functional design of the human lung for gas exchange. In A. P. Fishman, Editor-in-Chief. Fishman's Pulmonary Diseases and Disorders. International Edition, 3rd ed. McGraw-Hill, Health Professions Division, New York. 21-62.

22. Ding, D. J., J. G. Martin, and P. T. Maklem. 1987. Effects of lung volume on maximal methacholine-induced bronchoconstriction in normal humans. J. Appl. Physiol. 62: 1324-1330 [Abstract/Free Full Text].

23. Stephens, N. L., and H. Jiang. 1995. Basic physiology of the airway smooth muscle. In W. W. Busse and S. T. Holgate, editors. Asthma and Rhinitis. Blackwell Scientific Publications, Boston. 1087-1115.

24. Bramley, A. M., R. J. Thomson, C. R. Roberts, and R. R. Schellenberg. 1994. Hypothesis: excessive bronchoconstriction in asthma is due to decreased airway elastance. Eur. Respir. J. 7: 337-341 [Abstract].

25. Bousquet, J., A. M. Vignola, P. Chanez, A. M. Campbell, G. Bonsignore, and F. B. Michel. 1995. Airways remodelling in asthma: no doubt, no more? Int. Arch. Allergy Immunol. 107: 211-214 [Medline].

26. Roche, W. R.. 1998. Inflammatory and structural changes in the small airways in bronchial asthma. Am. J. Respir. Crit. Care Med. 157: S191-S194 .

27. Poulter, L. W. 1997. Central inflammation is more important than peripheral inflammation. Respir. Med. 91(Suppl. A):9-10.

28. Senior, R. M., N. L. Connolly, J. D. Cury, H. G. Welgus, and E. J. Campbell. 1989. Elastin degradation by human alveolar macrophages: a prominent role of metalloproteinase activity. Am. Rev. Respir. Dis. 139: 1251-1256 [Medline].

29. Campbell, E. J., E. K. Silverman, and M. A. Campbell. 1989. Elastase and cathepsin G of human monocytes: quantification of cellular content, release in response to stimuli, and heterogeneity in elastase- mediated proteolytic activity. J. Immunol. 143: 2961-2968 [Abstract].

30. Sibille, Y., and H. Y. Reynolds. 1990. Macrophages and polymorphonuclear neutrophils in lung defense and injury. Am. Rev. Respir. Dis. 141: 471-501 [Medline].

31. Lungarella, G., R. Menegazzi, C. Gardi, P. Spessotto, M. M. de Santi, P. Bertoncin, P. Patriarca, P. Calzoni, and G. Zabucchi. 1992. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch. Biochem. Biophys. 292: 128-135 [Medline].

32. Vignola, A. M., A. Bonanno, A. Mirabella, L. Riccobono, F. Mirabella, M. Profita, V. Bellia, J. Bousquet, and G. Bonsignore. 1998. Increased levels of elastase and alpha 1-antitrypsin in sputum of asthmatic patients. Am. J. Respir. Crit. Care Med. 157: 505-511 [Abstract/Free Full Text].

33. Suzuki, T., W. Wang, J. T. Lin, K. Shirato, H. Mitsuhashi, and H. Inoue. 1996. Aerosolized human neutrophil elastase induces airway constriction and hyperresponsiveness with protection by intravenous pretreatment with half-length secretory leukoprotease inhibitor. Am. J. Respir. Crit. Care Med. 153: 1405-1411 [Abstract].





This article has been cited by other articles:


Home page
Eur Respir JHome page
S. Siddiqui, F. Hollins, and C. E. Brightling
What can we learn about airway smooth muscle from the company it keeps?
Eur. Respir. J., July 1, 2008; 32(1): 9 - 11.
[Full Text] [PDF]


Home page
Eur Respir JHome page
B. B. Araujo, M. Dolhnikoff, L. F. F. Silva, J. Elliot, J. H. N. Lindeman, D. S. Ferreira, A. Mulder, H. A. P. Gomes, S. M. Fernezlian, A. James, et al.
Extracellular matrix components and regulators in the airway smooth muscle in asthma
Eur. Respir. J., July 1, 2008; 32(1): 61 - 69.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
A. L. James, F. H. Green, M. J. Abramson, T. R. Bai, M. Dolhnikoff, T. Mauad, K. O. McKay, and J. G. Elliot
Airway basement membrane perimeter distensibility and airway smooth muscle area in asthma
J Appl Physiol, June 1, 2008; 104(6): 1703 - 1708.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
P. N. Black, P. S. T. Ching, B. Beaumont, S. Ranasinghe, G. Taylor, and M. J. Merrilees
Changes in elastic fibres in the small airways and alveoli in COPD
Eur. Respir. J., May 1, 2008; 31(5): 998 - 1004.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A. L. James and S. Wenzel
Clinical relevance of airway remodelling in airway diseases
Eur. Respir. J., July 1, 2007; 30(1): 134 - 155.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. L. Sorkness, K. M. Herricks, R. J. Szakaly, R. F. Lemanske Jr, and L. A. Rosenthal
Altered allergen-induced eosinophil trafficking and physiological dysfunction in airways with preexisting virus-induced injury
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L85 - L91.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. F. Gelb, C. Flynn Taylor, C. M. Shinar, C. Gutierrez, and N. Zamel
Role of Spirometry and Exhaled Nitric Oxide To Predict Exacerbations in Treated Asthmatics
Chest, June 1, 2006; 129(6): 1492 - 1499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Kotaru, K. J. Schoonover, J. B. Trudeau, M.-L. Huynh, X. Zhou, H. Hu, and S. E. Wenzel
Regional Fibroblast Heterogeneity in the Lung: Implications for Remodeling
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1208 - 1215.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Wenzel
Severe Asthma in Adults
Am. J. Respir. Crit. Care Med., July 15, 2005; 172(2): 149 - 160.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. G. Xisto, L. L. Farias, H. C. Ferreira, M. R. Picanco, D. Amitrano, J. R. Lapa e Silva, E. M. Negri, T. Mauad, D. Carnielli, L. F. F. Silva, et al.
Lung Parenchyma Remodeling in a Murine Model of Chronic Allergic Inflammation
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 829 - 837.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.M. Vignola, F. Paganin, L. Capieu, N. Scichilone, M. Bellia, L. Maakel, V. Bellia, P. Godard, J. Bousquet, and P. Chanez
Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD
Eur. Respir. J., December 1, 2004; 24(6): 910 - 917.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. Series, J. Chakir, and D. Boivin
Influence of Weight and Sleep Apnea Status on Immunologic and Structural Features of the Uvula
Am. J. Respir. Crit. Care Med., November 15, 2004; 170(10): 1114 - 1119.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
P. K. Jeffery
Remodeling and Inflammation of Bronchi in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, November 1, 2004; 1(3): 176 - 183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
T. Mauad, L. F. F. Silva, M. A. Santos, L. Grinberg, F. D. C. Bernardi, M. A. Martins, P. H. N. Saldiva, and M. Dolhnikoff
Abnormal Alveolar Attachments with Decreased Elastic Fiber Content in Distal Lung in Fatal Asthma
Am. J. Respir. Crit. Care Med., October 15, 2004; 170(8): 857 - 862.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. F. Gelb, A. Schein, E. Nussbaum, C. M. Shinar, Y. Aelony, H. Aharonian, and N. Zamel
Risk Factors for Near-Fatal Asthma
Chest, October 1, 2004; 126(4): 1138 - 1146.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. J. Sterk
Heterogeneity of airway hyperresponsiveness: time for unconventional, but traditional, studies
J Appl Physiol, June 1, 2004; 96(6): 2017 - 2018.
[Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. I. Rennard and S. G. Farmer
Exacerbations and Progression of Disease in Asthma and Chronic Obstructive Pulmonary Disease
Proceedings of the ATS, April 1, 2004; 1(2): 88 - 92.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. E. McGowan, A. J. Holmes, and J. Smith
Retinoic acid reverses the airway hyperresponsiveness but not the parenchymal defect that is associated with vitamin A deficiency
Am J Physiol Lung Cell Mol Physiol, February 1, 2004; 286(2): L437 - L444.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
A.M. Vignola, A. Bonanno, M. Profita, L. Riccobono, N. Scichilone, M. Spatafora, J. Bousquet, G. Bonsignore, and V. Bellia
Effect of age and asthma duration upon elastase and {alpha}1-antitrypsin levels in adult asthmatics
Eur. Respir. J., November 1, 2003; 22(5): 795 - 801.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Niimi, H. Matsumoto, M. Takemura, T. Ueda, K. Chin, and M. Mishima
Relationship of Airway Wall Thickness to Airway Sensitivity and Airway Reactivity in Asthma
Am. J. Respir. Crit. Care Med., October 15, 2003; 168(8): 983 - 988.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
B. E. McParland, P. T. Macklem, and P. D. Pare
Airway wall remodeling: friend or foe?
J Appl Physiol, July 1, 2003; 95(1): 426 - 434.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. M. Vignola, F. Mirabella, G. Costanzo, R. Di Giorgi, M. Gjomarkaj, V. Bellia, and G. Bonsignore
Airway Remodeling in Asthma
Chest, March 1, 2003; 123(2007): 417S - 422S.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
P A Beckett and P H Howarth
Pharmacotherapy and airway remodelling in asthma?
Thorax, February 1, 2003; 58(2): 163 - 174.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
K. Wassermann
Is Asthma Another Interstitial Lung Disease?
Chest, March 1, 2002; 121(3): 673 - 674.
[Full Text] [PDF]


Home page
ChestHome page
A. F. Gelb, J. Licuanan, C. M. Shinar, and N. Zamel
Unsuspected Loss of Lung Elastic Recoil in Chronic Persistent Asthma
Chest, March 1, 2002; 121(3): 715 - 721.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. S. Faffe, P. R. M. Rocco, E. M. Negri, and W. A. Zin
Comparison of rat and mouse pulmonary tissue mechanical properties and histology
J Appl Physiol, January 1, 2002; 92(1): 230 - 234.
[Abstract] [Full Text] [PDF]


Home page